The expression of four genes (CER1, FRAT1, FSTL1, and RPSA) involved in the Wnt/β-catenin pathway was significantly associated with mortality and disease progression in patients with glioma, especially in those with grade III glioma. Here, FSTL1 is linked to glioma.